|drug3375||The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: Wiki||1.00|
|D009080||Mucocutaneous Lymph Node Syndrome NIH||1.00|
|D001997||Bronchopulmonary Dysplasia NIH||1.00|
|D014552||Urinary Tract Infections NIH||1.00|
|D004314||Down Syndrome NIH||1.00|
|D000309||Adrenal Insufficiency NIH||1.00|
|D001289||Attention Deficit Disorder with Hyperactivity NIH||0.58|
|D020141||Hemostatic Disorders NIH||0.26|
|D001778||Blood Coagulation Disorders NIH||0.26|
|D003141||Communicable Diseases NIH||0.07|
|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
|D018352||Coronavirus Infections NIH||0.03|
|HP:0000846||Adrenal insufficiency HPO||1.00|
There is one clinical trial.
The Açaí trial will be testing if the açaí berry extract, a safe natural product with anti-inflammatory properties, can be used as a treatment option in adult patients with COVID-19 in the community.
Description: Symptom comparison between patients from the treatment vs control group, using an ordinal symptom scale based on the WHO scale. Patients who were hospitalized will be classified according to their worst score over 30 days and non-hospitalized patients according to their score at 30 days.Measure: 7-point ordinal symptom scale Time: 30 days
Description: First occurrence of all-cause mortality or need for mechanical ventilationMeasure: The composite of all-cause mortality and need for mechanical ventilation Time: 30 days
Description: First occurrence of all-cause mortality or hospitalizationMeasure: The composite of all-cause mortality and hospitalization Time: 30 days
Description: All-cause mortalityMeasure: All-cause mortality Time: 30 days
Description: Need for mechanical ventilationMeasure: Need for mechanical ventilation Time: 30 days
Description: Need for hospitalizationMeasure: Need for hospitalization Time: 30 days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports